The forecast for the number of multidrug-resistant tuberculosis cases started on treatment in France shows a relatively stable trend. From 2024 to 2028, the cases are expected to increase slightly from 44 to 45 annually. This indicates a minimal year-on-year variation of about 2.3%. These forecasted figures suggest almost negligible change, highlighting the consistent efforts to manage drug-resistance in tuberculosis over the years.
Looking forward, it will be crucial to watch advancements in medical treatments and public health policies which may impact these numbers. Improvements in early detection and innovative treatment strategies could alter these projections, potentially leading to a decrease in cases or a more dynamic trend in future forecasts.
